Theraclone Sciences
Seattle, US
Biotech
Founders & leadership
SG
Steven GillisExecutive Officer, Director
KS
Kristine SwiderekExecutive Officer
WH
Wende HuttonDirector
RH
Russ HawkinsonExecutive Officer
WR
Wendye RobbinsDirector
CS
Clifford StocksExecutive Officer, Director
CM
Christopher MirabelliDirector
Reported raises · per SEC filings
Form D private placements$3.1MraisedMay 2015 · 12 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.